Viewing Study NCT04328727

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:19 AM
Ignite Modification Date: 2025-12-26 @ 4:26 AM
Study NCT ID: NCT04328727
Status: COMPLETED
Last Update Posted: 2025-07-17
First Post: 2020-03-09
Is NOT Gene Therapy: False
Has Adverse Events: True
Brief Title: Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Severe Aplastic Anemia (SAA) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Treatment naïve severe aplastic anemia View
None SAA View
None eltrombopag View
None ETB115 View
None immunosuppressive therapy View
None rabbit anti-thymocyte globulin View
None r-ATG View
None cyclosporine A View
None CsA View
None East-Asian patients View